Oliver MF (1982) Diet and coronary heart disease. Hum Nutr Clin Nutr 36, 413–427.
Nordoy A & Goodnight SH (1990) Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 10, 149–163.
Shrapnel WS, Calvert GD, Nestel PJ & Truswell AS (1992) Diet and coronary heart disease. The National Heart Foundation of Australia. Med J Aust 156, S9–S16.
Dyerberg J & Bang HO (1982) A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest 161, Suppl., 7–13.
Hu FB & Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288, 2569–2578.
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM & Kupelnick B (2006) n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A & Breteler MM (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42, 776–782.
Kalmijn S (2000) Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging 4, 202–207.
Barberger-Gateau P, Letenneur J, Deschamps V, Peres K, Dartigues JF & Renaud S (2002) Fish, meat, and risk of dementia: cohort study. Br Med J 325, 932–933.
Morris MC, Evans DA, Tangney CC, Bienias JL & Wilson RS (2005) Fish consumption and cognitive decline with age in a large community study. Arch Neurol 62, 1849–1853.
WHO and FAO Joint Consultation (1995) Fats and oils in human nutrition. Nutr Rev 53, 202–205.
Simopoulos AP, Leaf A & Salem N (1999) Workshop on the Essentiality of and Recommended Dietary Intakes for n-6 and n-3 Fatty Acids. Bethesda, MD: National Institutes of Health.
Scientific Review Committee (1990) Nutrition Recommendations. Ottawa: Canadian Government Publishing Centre, Supply and Services Canada.
COMA Cardiovascular Review Group (1994) Report on Health and Social Subjects: Nutritional Aspects of Cardiovascular Disease. . London: Department of Health.
Carlson SE (2001) Docosahexaenoic acid and arachidonic acid in infant development. Semin Neonatol 6, 437–449.
Larque E, Demmelmair H & Koletzko B (2002) Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann N Y Acad Sci 967, 299–310.
Crawford MA, Golfetto I, Ghebremeskel K, Min Y, Moodley T, Poston L, Phylactos A, Cunnane S & Schmidt W (2003) The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 38, 303–315.
Groot RH, Hornstra G, van Houwelingen AC & Roumen F (2004) Effect of alpha-linoleic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am J Clin Nutr 79, 251–260.
Innis SM, Adamkin DH, Hall RT, et al. (2002) Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. J Pediatr 140, 547–554.
Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, Hansen JW & Diersen-Schade DA (2005) Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 146, 461–468.
Agostoni C, Trojan S, Bellu R, Riva E & Giovannini M (1995) Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res 38, 262–266.
Birch EE, Garfield S, Hoffman DR, Uauy R & Birch DG (2000) A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 42, 174–181.
Bouwstra H, Dijck-Brouwer DAJ, Wildeman JAL, Tjoonk HM, Van der Heid JC, Boersma ER, Muskiet FAJ & Hadders-Algra M. (2003) Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am J Clin Nutr 78, 313–318.
ESPGAN (European Society of Pediatric Gastroenterology and Nutrition) Committee on Nutrition (1991) Comment on the content and composition of lipids in infant formulas. Acta Paediatr Scand 80, 887–896.
The British Nutrition Foundation (1992) Recommendations for intakes of unsaturated fatty acids. In Unsaturated Fatty Acids: Nutritional and Physiological Significance, pp. 153–163. London: Chapman and Hall, .
Report of the SCF (Scientific Committee on Food) .
Brenner RR (1977) Regulatory function of delta6 desaturate – key enzyme of polyunsaturated fatty acid synthesis. Adv Exp Med Biol 83, 85–101.
Burdge GC, Jones AE & Wootton SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 88, 355–363.
Pawlosky R, Hibbeln J, Lin Y, Salem N Jr & Burdge G (2003) Nutrition Discussion Forum. Br J Nutr 90, 993–995.
De Gomez-Dumm I & Brenner RR (1974) Oxidative desaturation of alpha-linolenic, linoleic and stearic acids in human liver microsomes. Lipids 10, 315–317.
McCloy U, Ryan MA, Pencharz PB, Ross RJ & Cunnane C (2004) A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J Lipid Res 45, 474–485.
Miyamoto E (2006) Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci 100, 433–442.
Lynch MA & Voss KL (1994) Membrane AA concentration correlates with age and induction of long-term potentiation in the dentate gyrus in the rat. Eur J Neurosci 6, 1008–1014.
Murray CA & Lynch MA (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci 18, 2974–2981.
Lynch MA, Voss KL & Gower AJ (1994) Impaired spatial memory in aged rats is associated with alterations in inositol phospholipid metabolism. Neuroreport 5, 1493–1497.
McGahon B, Clements MP & Lynch MA (1997) The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane AA concentration is reversed. Neuroscience 81, 9–16.
McGahon BM, Murray CA, Horrobin DF & Lynch MA (1999) Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol Aging 20, 643–653.
Kotani S, Nakazawa H, Tokimasa T, Akimoto K, Kawashima H, Toyoda-Ono Y, Kiso Y, Okaichi H & Sakakibara M (2003) Synaptic plasticity preserved with AA diet in aged rats. Neurosci Res 46, 453–461.
Sakuradani E, Kobayashi M & Shimizu S (1999) Δ9-Fatty acid desaturase from arachidonic acid-producing fungus: unique gene sequence and its heterologous expression in a fungus. Eur J Biochem 260, 208–216.
Streekstra H (1997) Review: On the safety of Mortierella alpine for the production of food ingredients, such as arachidonic acid. J Biotechnol 56, 153–165.
Hempenius RA, van Delft JMH, Prinsen M & Lina BAR (1997) Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpine: summary of toxicological data. Food Chem Toxicol 35, 573–581.
Hempenius RA, Lina BAR & Haggit RC (2000) Evaluation of a sub-chronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonic acid oil derived from Mortierella alpine in rats. Food Chem Toxicol 38, 127–139.
Lina BAR, Wolterbeek APM, Suwa Y, Fujikawa S, Ishikura Y, Tuda S & Dohnalek M (2006) Subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonate-enriched triglyceride oil (SUNTGA 40S) in rats. Food Chem Toxicol 44, 326–335.
Nelson GJ, Kelley DS, Emken EA, Phinney SD, Kyle D & Ferretti A (1997) A human dietary arachidonic acid supplementation study conducted in a metabolic research unit: rationale and design. Lipids 32, 415–420.
Nelson GJ, Schmidt PC, Bartolini G, Kelley DS & Kyle D (1997) The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32, 421–425.
Nelson GJ, Schmidt PC, Bartolini G, Kelley DS, Phinney SD, Kyle D, Silbermann S & Schaefer EJ (1997) The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids 32, 427–433.
Pantaleo P, Marra F, Vizzutti F, Spadoni S, Ciabattoni G, Galli C, Villa GL, Gentilini P & Laffi G (2004) Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. Clin Sci 106, 27–34.
Nakamura T, Takebe K, Tando Y, Arai Y, Yamada N, Ishii M, Kikuchi H, Machida K, Imamura K & Terada A (1995) Serum fatty acid composition in normal Japanese and its relationship with dietary fish and vegetable oil contents and blood lipid levels. Ann Nutr Metab 39, 261–270.
Sugano M & Hirahara F (2000) Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr 71, 189S–196S.
Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M & Tsugane S (2001) Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 55, 643–650.
Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Tsugane S & JPHC (2003) Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: comparison with dietary records and serum phospholipid level. J Epidemiol 13, Suppl. 1, S64–S81.
Kuriki K, Nagaya T & Tokudome Y (2003) Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133, 3643–3650.
Ministry of Education, Culture, Sports, Science and Technology (2005) Fatty acids section. In Standard Tables of Food Composition in Japan, 5th ed. Tokyo: Ministry of Education, Culture, Sports, Science and Technology.
Folch J, Lees M & Stanley GHS (1957) A Simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497–509.
Ikuta S, Imamura S, Misaki H & Horiuti Y (1977) Purification and characterization of choline oxidase from Arthrobacter globiformis. J Biochem 82, 1741–1749.
Warnick GR, Nauck M & Rifai N (2001) Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 47, 1579–1596.
Nauck M, Warnick GR & Rifai N (2002) Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48, 236–254.
Sakurabayashi I (1986) Latex-agglutination immunoassay. Rinsho Byori 34, 887–892.
Kanno T (1987) Automation of the immunochemical laboratory using the latex agglutination reaction. Rinsho Byori 35, 874–877.
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927–929.
Packham MA (1984) Standardization of collagen: consideration of current practices in testing collagen-induced aggregation. Thromb Haemost 52, 358–361.
Shimokata H, Ando F & Niino N (2000) A new comprehensive study on aging – the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol 10, S1–S9.
Imai T, Sakai S, Mori K, Ando F, Niino N & Shimokata H (2000) Nutritional assessments of 3-d dietary records in National Institute for Longevity Sciences – Longitudinal Study of Aging (NILS-LSA). J Epidemiol 10, S70–S76.
Ueshima H, Okayama A, Saitoh S, Nakagawa H, Rodriguez B, Sakata K, Okuda N, Choudhury SR & Curb JD (2003) Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID study. J Hum Hypertens 17, 631–639.
Okuda N, Ueshima H, Okayama A, Saitoh S, Nakagawa H, Rodriguez B, Sakata K, Choudhury SR & Curb JD (2005) Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. Atherosclerosis 178, 371–379.
Sanders TAB (2000) Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr 71, 176S–178S.
Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA & Calder PC (2001) Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr 73, 539–548.
Nelson GJ, Schmidt PC & Corash L (1991) The effect of a salmon diet on blood clotting, platelet aggregation and fatty acids in normal adult men. Lipids 26, 87–96.
Lahoz C, Alonso R, Ordovas JM, Lopez-Farre A, de Oya M & Mata P (1997) Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest 27, 780–787.
Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G & Etherton TD (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71, 179S–188S.
Geppert J, Kraft V, Demmelmair H & Koletzko B (2005) Docosahexaenoic acid supplementation in vegetarians effectively increase omega-3 index: a randomized trial. Lipids 40, 807–814.
Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB & Borkon AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients. Correlation with erythrocytes and response to supplementation. Circulation 110, 1645–1649.
Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O & Uusitupa MI (1997) Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32, 697–705.
Rogers S, James KS, Butland BK, Etherington MD, O'Brien JR & Jones JG (1987) Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis 63, 137–143.
Kristensen SD, Schmidt EB & Dyerberg J (1989) Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med 731, Suppl., 141–150.
Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frolich JC, Heimberg M & Oates JA (1975) Increased arachidonate in lipids after administration to man: effects of prostaglandin biosynthesis. Clin Pharmacol Therapeut 18, 521–529.